Agarwal SM, Nandekar P, Saini R (2022) Computational identification of natural product inhibitors against EGFR double mutant (T790M/L858R) by integrating ADMET, Machine Learning, molecular docking and a dynamics approach. RSC Adv 12(26):16779–16789. https://doi.org/10.1039/d2ra00373b
Article CAS PubMed PubMed Central Google Scholar
Ahmadpour S, Hosseinimehr SJ (2019) Recent developments in peptide-based SPECT radiopharmaceuticals for breast tumor targeting. Life Sci 239:116870. https://doi.org/10.1016/j.lfs.2019.116870
Article CAS PubMed Google Scholar
Ahmed S, Kaur K (2017) Design, synthesis and validation of an in vitro platform peptide-whole cell screening assay using MTT reagent. J Taibah Univ Sci 11(3):487–496. https://doi.org/10.1016/j.jtusci.2016.10.001
Albuschies J, Vogel V (2013) The role of filopodia in the recognition of nanotopographies. Sci Rep 3:1658. https://doi.org/10.1038/srep01658
Article CAS PubMed PubMed Central Google Scholar
Askoxylakis V, Mier W, Zitzmann S, Ehemann V, Zhang J, Krämer S, Beck C, Schwab M, Eisenhut M, Haberkorn U (2006) Characterization and development of a peptide (p160) with affinity for neuroblastoma cells. J Nucl Med 47(6):981–988
Azuaje F (2017) Computational models for predicting drug responses in cancer research. Brief Bioinform 18(5):820–829. https://doi.org/10.1093/bib/bbw065
Article CAS PubMed Google Scholar
Bag BG, Paul K (2012) Vesicular and fibrillar gels by self-assembly of nanosized oleanolic acid. Asian J Org Chem 1:150–154. https://doi.org/10.1002/ajoc.201200032
Bag BG, Das S, Hasan SN, Barai AC (2017) Nanoarchitectures by hierarchical self-assembly of ursolic acid: entrapment and release of fluorophores including anticancer drug doxorubicin. RSC Adv 7(29):18136–18143. https://doi.org/10.1039/C7RA02123B
Banks JL, Beard HS, Cao Y, Cho AE, Damm W, Farid R, Felts AK, Halgren TA, Mainz DT, Maple JR, Murphy R, Philipp DM, Repasky MP, Zhang LY, Berne BJ, Friesner RA, Gallicchio E, Levy RM (2005) Integrated Modeling Program, Applied Chemical Theory (IMPACT). J Comput Chem 26(16):1752–1780. https://doi.org/10.1002/jcc.20292
Article CAS PubMed PubMed Central Google Scholar
Barker AJ, Gibson KH, Grundy W, Godfrey AA, Barlow JJ, Healy MP, Woodburn JR, Ashton SE, Curry BJ, Scarlett L, Henthorn L, Richards L (2001) Studies leading to the identification of ZD1839 (Iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett 11(14):1911–1914. https://doi.org/10.1016/s0960-894x(01)00344-4
Article CAS PubMed Google Scholar
Bell RA, Storey KB (2014) Novel detection method for chemiluminescence derived from the Kinase-Glo luminescent kinase assay platform: advantages over traditional microplate luminometers. MethodsX 1:96–101. https://doi.org/10.1016/j.mex.2014.07.003
Article PubMed PubMed Central Google Scholar
Bergdorf M, Baxter S, Rendleman CA, Shae DE (2016) Desmond/GPU performance as of November 2016. D.E. Shaw Research Technical Report DESRES/T-2019-01. https://www.deshawresearch.com/publications/Desmond-GPU%20Performance%20as%20of%20November%202016.pdf. Accessed 27 July 2023
Beyett TS, To C, Heppner DE, Rana JK, Schmoker AM, Jang J, Clercq D, Gomez G, Scott D, Gray NS, Janne P, Eck MJ (2022) Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors. Nat Commun 13(1):2530. https://doi.org/10.1038/s41467-022-30258-y
Article CAS PubMed PubMed Central Google Scholar
Bose R, Zhang X (2009) ErbB kinase domain: structural perspectives into kinase activation and inhibition. Exp Cell Res 315(4):649–658. https://doi.org/10.1016/j.yexcr.2008.07.031
Article CAS PubMed Google Scholar
Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK, Shan Y, Shaw DE (2006) Molecular Dynamics—Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proc ACM/IEEE Conf SC06 84-es. https://doi.org/10.1145/1188455.1188544
Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F (2005) Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res 7(5):R788–R795. https://doi.org/10.1186/bcr1304
Article CAS PubMed PubMed Central Google Scholar
Cataldo VD, Gibbons DL, Pérez-Soler R, Quintás-Cardama A (2011) Treatment of non-small cell lung cancer with erlotinib or gefitinib. N Engl J Med 364(10):947–955. https://doi.org/10.1056/NEJMct0807960
Article CAS PubMed Google Scholar
Chadalapaka G, Jutooru I, Burghardt R, Safe S (2010) Drugs that target specificity proteins downregulate epidermal growth factor receptors in bladder cancer cells. Mol Cancer Res 8(5):739–750. https://doi.org/10.1158/1541-7786.MCR-09-0493
Article CAS PubMed PubMed Central Google Scholar
Chen S, Zhao X, Chen J, Chen J, Kuznetsova L, Wong SS, Ojima I (2010) Mechanism-based tumor-targeting drug delivery system Validation of efficient vitamin receptor-mediated endocytosis and drug release. Bioconj. Chem 21(5):979–987. https://doi.org/10.1021/bc9005656
Cheng Z, Li M, Dey R, Chen Y (2021) Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol 14(1):85. https://doi.org/10.1186/s13045-021-01096-0
Article PubMed PubMed Central Google Scholar
Costa SA, Mozhdehi D, Dzuricky MJ, Isaacs FJ, Brustad EM, Chilkoti A (2019) Active targeting of cancer cells by nanobody decorated polypeptide micelle with bio-orthogonally conjugated drug. Nano Lett 19(1):247–254. https://doi.org/10.1021/acs.nanolett.8b03837
Article CAS PubMed Google Scholar
Dasmahapatra U, Kumar CK, Das S, Subramanian PT, Murali P, Isaac AE, Ramanathan K, Mm B, Chanda K (2022) In-silico molecular modelling, MM/GBSA binding free energy and molecular dynamics simulation study of novel pyrido fused imidazo[4,5-c]quinolines as potential anti-tumor agents. Front Chem 10:991369. https://doi.org/10.3389/fchem.2022.991369
Article CAS PubMed PubMed Central Google Scholar
Debala DT, Muzazu SGY, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Mayazewal T (2021) New approaches and procedures for cancer treatment: current perspectives. Sage Open Med 9:20503121211034370. https://doi.org/10.1177/20503121211034366
Du Z, Lovly CM (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. https://doi.org/10.1186/s12943-018-0782-4
Article PubMed PubMed Central Google Scholar
Durrant JD, McCammon JA (2011) Molecular dynamics simulations and drug discovery. BMC Biol 9:71. https://doi.org/10.1186/1741-7007-9-71
Article CAS PubMed PubMed Central Google Scholar
Emami L, Khabnadideh S, Faghih Z, Farahvasi F, Zonobi F, Gheshlaghi SZ, Daili S, Ebrahimi A, Faghih Z (2022) Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents. BMC Chem 16(1):100. https://doi.org/10.1186/s13065-022-00893-z
Article CAS PubMed PubMed Central Google Scholar
Ferdausi N, Islam S, Rimti FH, Quayum ST, Arshad EM, Ibnat A, Islam T, Arefin A, Ema TI, Biswas P, Dey D, Al Azad S (2022) Point-specific interactions of isovitexin with the neighboring amino acid residues of the hACE2 receptor as a targeted therapeutic agent in suppressing the SARS-CoV-2 influx mechanism. J Adv Vet Anim Res 9(2):230–240. https://doi.org/10.5455/javar.2022.i588
Article PubMed PubMed Central Google Scholar
Filipe V, Hawe A, Jiskoot W (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by nanosight for the measurement by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27(5):796–810. https://doi.org/10.1007/s11095-010-0073-2
Article CAS PubMed PubMed Central Google Scholar
Fischer M (2010) Amine coupling through EDC/NHS: a practical approach. Methods Mol Biol 627:55–73. https://doi.org/10.1007/978-1-60761-670-2_3
Article CAS PubMed Google Scholar
Forouzesh N, Mishra N (2021) An effective MM/GBSA protocol for absolute binding free energy calculations: a case study on SARS-CoV-2 spike protein and the human ACE2 receptor. Molecules 26(8):2383. https://doi.org/10.3390/molecules26082383
Article CAS PubMed PubMed Central Google Scholar
Fry DW, Bridges AJ, Denny WA, Doherty A, Greis KD et al (1998) Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. Proc Natl Acad Sci USA 95(20):12022–12027. https://doi.org/10.1073/pnas.95.20.12022
Article CAS PubMed PubMed Central Google Scholar
Gajiwala KS, Feng J, Ferre R, Ryan K, Brodsky O, Weinrich S, Kath JC, Stewart A (2013) Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition. Structure 21(2):209–219. https://doi.org/10.1016/j.str.2012.11.014
Article CAS PubMed Google Scholar
Gao H, Wang Y, Chen C, Chen J, Wei Y, Cao S, Jiang X (2014) Incorporation of lapatinib into core-shell nanoparticles improves both the solubility and anti-glioma effects of the drug. Int J Pharm 461(1–2):478–488. https://doi.org/10.1016/j.ijpharm.2013.12.016
留言 (0)